Frederick Beddingfield III, Chief Medical Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 30,583 shares at $75.74 ($2.3M) on 2015-06-25, disclosed to the SEC on 2015-06-25.
Open-market sale of $2.3M KYTH by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.52 | 11,040 | $834K | 36.0% |
| 2 | $75.74 | 19,543 | $1.5M | 64.0% |
| Total | $75.66 avg | 30,583 | $2.3M | 100% |
| Filing → |
| KYTH | SELL | 2015-04-30 | $93K | — | Filing → |